Although microangiopathic hemolysis (MAH) is a well-known complication of malignant phase hypertension (MPH), only less data on whether MAH in MPH predicts renal outcome exist.  Therefore, we evaluated whether MAH was associated with the renal outcome in patients with MPH.



THERM